Skip to main content

Integrin alpha-6 drives metabolic adaptation and breast cancer survival in leptomeningeal metastasis

Research Grant
Duke Scholars

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

June 15, 2026

End Date

May 31, 2031
 

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

June 15, 2026

End Date

May 31, 2031